Modeling human neurodegenerative diseases in transgenic systems.
about
Neural stem/progenitor cells in Alzheimer's diseaseRegeneration, Plasticity, and Induced Molecular Programs in Adult Zebrafish BrainDisrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal modelsC. elegans expressing human β2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotypeGenetic variants associated with neurodegenerative Alzheimer disease in natural modelsSynaptic abnormalities in a Drosophila model of Alzheimer's diseaseDeregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model.Bovine Brain: An in vitro Translational Model in Developmental Neuroscience and Neurodegenerative ResearchPrion protein facilitates synaptic vesicle release by enhancing release probability.mNos2 deletion and human NOS2 replacement in Alzheimer disease modelsWnt Signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice.Mechanisms, models and biomarkers in amyotrophic lateral sclerosisIdentification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.Lessons from the analysis of nonhuman primates for understanding human aging and neurodegenerative diseasesXyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.Human pluripotent stem cells: applications and challenges in neurological diseases.Quantitative mouse brain phenotyping based on single and multispectral MR protocols.Models for preclinical studies in aging-related disorders: One is not for all.Thinking laterally about neurodegenerative proteinopathies.Modeling Alzheimer's disease: from past to futureThe Simple Chordate Ciona intestinalis Has a Reduced Complement of Genes Associated with Fanconi Anemia.Protein folding and aggregation into amyloid: the interference by natural phenolic compoundsCRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling.Genome resource banking of biomedically important laboratory animals.Oxidative stress in genetic mouse models of Parkinson's disease.Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation.Wisdom from the fly.From Neurodegeneration to Brain Health: An Integrated Approach.Effects of transgenic sterilization constructs and their repressor compounds on hatch, developmental rate and early survival of electroporated channel catfish embryos and fry.FTD and ALS--translating mouse studies into clinical trials.Noncoding RNAs in protein clearance pathways: implications in neurodegenerative diseases.Role of Plant Polyphenols in Alzheimer's Disease.Prion protein as a mediator of synaptic transmissionAggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent.Mass Histology to Quantify Neurodegeneration in Drosophila.Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease.Differential centrifugation-based biochemical fractionation of the Drosophila adult CNS.Time to recognize zebrafish ‘affective’ behavior
P2860
Q26738352-D0973A36-B169-410E-B1B1-6F0F5ED6A31EQ26784566-0BC2EB08-B622-4CE9-938E-8209B598FF67Q26995918-3A0F65D3-5571-4408-9A1B-F85F2E5C4A0BQ27325393-C1AA93F2-99C0-4EC6-B7F9-71B282DE6FD2Q28079843-78F23A70-3148-4067-B2A9-4D921FF32491Q30573528-A4096D24-627D-4761-AE84-6B6AC2AC80A0Q33659976-E5058164-46F1-4D4C-81E1-049F353C04D3Q33876851-6256F9CA-16F9-4000-B63F-D1185BA50396Q33991740-F60702CB-81B2-4FE6-9BC0-1B208106DB7EQ34041402-CE8F52BE-32F0-45C8-AC53-E4E00BA2A40AQ34222827-EE162196-7968-4E22-A02D-8C96DC880F72Q34344992-14994300-7B79-4445-B86D-FC7D53C91C79Q35085348-929D8B7B-EFEE-4200-8D6D-B1BE29EB0229Q35145776-B8189E2C-9149-4B94-90BC-789C859741A5Q35997893-224D42BD-B20C-4F3B-B625-252701704859Q36193696-AA5B75D7-8B6E-43DB-A1BA-7B7A47E56635Q36706021-59CF308E-7C2B-407A-BBC1-1CDCD1E2FFDFQ36738466-478F505F-E647-4D03-BAC1-CC8A83B46032Q36793466-1BB5341D-522F-4C79-B90F-8EA809FE83B6Q36938165-F3161473-6343-4E21-9817-86F64AB85BA8Q36982306-6D8E977D-8158-4DAD-83E2-58ADBB8828CBQ37007345-1B0A722B-0E3D-4D33-B6FE-67D29C2542DCQ37559474-5936C374-B492-4B17-8CA4-F8D77C41C76AQ37612445-04580D97-8EC7-47BD-B60E-24566038B733Q38029327-579216D9-3174-4B44-AC2F-1DAB97335870Q38217070-CF92C0FF-5FBE-4366-A124-EF9381A9958FQ38243755-843B5C80-46BA-4F69-BD2A-71C2D61CE353Q38365566-D5EF890E-476F-4766-82A4-B338C3516159Q38415660-AB25FD79-2104-41EF-80F2-678FE128A6D0Q38457811-DB81E5FB-CB2E-4FC0-9FE7-7FCE565B8286Q38866142-FD05B1D9-5E79-4619-A0B3-68AE69A14AC6Q39167148-9069F482-5A16-4782-9489-906D4C61654AQ41277418-E6841889-4C8D-4C2B-926B-7CE37F3D9A92Q41523783-AC856868-4867-4915-BD60-B227B1B08DD6Q45924774-47E83645-2CE2-490D-9FDB-55C9B4863C79Q48369311-92CFA1A2-9B26-46DE-BCD7-DB1E769E6BACQ51533022-E6403564-692F-4CC2-8311-BE257D3376B2Q52782412-B9E1FBB4-6BE9-4140-94CD-0D48253F07F6Q58012123-6327111B-292A-4838-9825-5BC2C07E4F3D
P2860
Modeling human neurodegenerative diseases in transgenic systems.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modeling human neurodegenerative diseases in transgenic systems.
@en
Modeling human neurodegenerative diseases in transgenic systems.
@nl
type
label
Modeling human neurodegenerative diseases in transgenic systems.
@en
Modeling human neurodegenerative diseases in transgenic systems.
@nl
prefLabel
Modeling human neurodegenerative diseases in transgenic systems.
@en
Modeling human neurodegenerative diseases in transgenic systems.
@nl
P2093
P2860
P1433
P1476
Modeling human neurodegenerative diseases in transgenic systems.
@en
P2093
Gregory A Elder
Miguel A Gama Sosa
Rita De Gasperi
P2860
P2888
P304
P356
10.1007/S00439-011-1119-1
P577
2011-12-14T00:00:00Z